EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Health risks of N,N -dimethylacetamide (DMAC) in humans

Tetsuo Nomiyama iD, Teruomi Tsukahara, Kohei Hasegawa iD

Journal of Occupational Health · 07.01.2025 · 67 (1)

DOI: 10.1093/joccuh/uiaf010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Occupational Health, online erschienen am 07.02.2025. Verfasst von Tetsuo Nomiyama und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine and Public Health, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan. Hauptthemen laut MEDLINE: Acetamides, Occupational Exposure, Solvents, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N,N-Dimethylacetamide (DMAC), which is widely used as an industrial solvent, can be absorbed via the respiratory tract and skin of humans exposed to it. Hepatotoxicity is a main health risk of DMAC exposure in humans, and the relevant cases and epidemiological studies are reviewed herein. No hepatotoxicity was identified in workers exposed to ~3 ppm DMAC, and among workers exposed to >9 ppm DMAC the DMAC exposure was not observed to contribute significantly to liver damage. However, a case of liver damage was identified in which the calculated 8-hour weighted average was 12.8 mg/m3 (3.6 ppm). The skin absorption notation for DMAC is indicated based on human volunteer studies. The evidence regarding DMAC’s potential carcinogenicity in humans is not sufficient, and our literature search identified no report of DMAC as a reproductive toxicant in humans. Further case reports and epidemiological studies are necessary to determine the acceptable DMAC exposure limit for workers and thus protect them from DMAC’s toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetamidesOccupational ExposureSolventsChemical and Drug Induced Liver InjuryHumansSkin Absorption

Stichwörter der Autor:innen

N,N-dimethylacetamideacceptable exposure limitdermal absorptionhepatotoxicityoccupational exposureoccupational exposure limit

Substanzen

AcetamidesdimethylacetamideSolvents

Autor:innen und Institutionen

  • Department of Preventive Medicine and Public Health, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.
  • Center for Epidemiologic Research, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.
  • Center for Perinatal, Pediatric and Environmental Epidemiology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.
  • Department of Occupational Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.

ORCID-Profile: Tetsuo Nomiyama, Kohei Hasegawa

Zitieren

APA

Nomiyama, T., Tsukahara, T., & Hasegawa, K. (2025). Health risks of N,N -dimethylacetamide (DMAC) in humans. Journal of Occupational Health, 67(1). https://doi.org/10.1093/joccuh/uiaf010

Vancouver

Nomiyama T, Tsukahara T, Hasegawa K. Health risks of N,N -dimethylacetamide (DMAC) in humans. Journal of Occupational Health. 2025;67(1). doi:10.1093/joccuh/uiaf010

BibTeX
@article{Nomiyama2025,
  author = {Nomiyama, Tetsuo and Tsukahara, Teruomi and Hasegawa, Kohei},
  title = {Health risks of N,N -dimethylacetamide (DMAC) in humans},
  journal = {Journal of Occupational Health},
  year = {2025},
  volume = {67},
  number = {1},
  doi = {10.1093/joccuh/uiaf010}
}
Kostenlos starten →